BOB FoodTech
Metabolite-Clearing RNA System for Cell-Based Protein
Company Overview
Snapshot
Founded in September 2023 by Tal Malca Salhuv and Professor Ehud Gazit, BOB FoodTech operates with 1–10 employees. The company has raised $707.5K across two funding rounds. In September 2023, The Kitchen FoodTech Hub led its Pre-Seed funding round.
Business overview
BOB FoodTech develops a proprietary RNA-encapsulation platform designed to enable the recycling of cell-culture media within the cultivated-meat and seafood industries. The company's technology utilizes stabilized RNA constructs, referred to as Bio Optimal Binding (BOB) particles, to bind and remove metabolic by-products such as lactate and ammonia from bioreactor systems. This approach aims to address cost and waste challenges in cell-ag operations, thereby improving process economics and sustainability for cultivated-protein producers. The company operates within the Agriculture & Food Technologies sector, focusing on areas like Ag Tech, Food Tech, Sustainable Proteins, and Sustainable Farming.
Company Intelligence Q&A
- What is BOB FoodTech's core technology?
- BOB FoodTech develops a proprietary RNA-encapsulation platform that utilizes stabilized RNA constructs, known as Bio Optimal Binding (BOB) particles, to bind and remove metabolic by-products from bioreactor systems. This technology is designed to enable the recycling of cell-culture media in the cultivated-meat and seafood industries.
- When was BOB FoodTech founded and by whom?
- BOB FoodTech was founded in September 2023 by Tal Malca Salhuv and Professor Ehud Gazit.
- What was BOB FoodTech's most recent funding event?
- In September 2023, BOB FoodTech secured Pre-Seed funding led by.
- Which accelerator program did BOB FoodTech join?
- In October 2024, BOB FoodTech received a grant from the EIT Food Accelerator Network.
- What problem does BOB FoodTech aim to solve in the cultivated protein industry?
- BOB FoodTech aims to address cost and waste issues in cell-ag operations by reducing the accumulation of inhibitory metabolites and enabling media reuse. This improves process economics and sustainability for cultivated-protein producers.